NI
GSK icon

Natural Investments’s GSK GSK Stock Holding History

Natural Investments’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$405K Buy
7,726
+211
+3% +$11.2K 0.09% 183
2026
Q1 		$414K Sell
7,515
-91
-1% -$4.93K 0.1% 181
2025
Q4 		$372K Buy
7,606
+2,134
+39% +$99.5K 0.09% 189
2025
Q3 		$236K Sell
5,472
-95
-2% -$3.71K 0.06% 207
2025
Q2 		$213K Buy
+5,567
New +$213K 0.06% 237

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Natural Investments's GSK Position: Q2 2026 in Review

Natural Investments increased its GSK (GSK) stake by 2.8% in Q2 2026, buying an estimated $11.2K and bringing the position to 7,726 shares worth $405K. The position accounts for 0.09% of the portfolio, ranked #183.

Natural Investments first reported a position in GSK in Q2 2025 and has held it in 5 quarters since. The position peaked at $414K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Natural Investments held 7,726 shares of GSK worth $405K as of Q2 2026.
  • Natural Investments bought 211 GSK shares in Q2 2026, an estimated $11.2K.
  • GSK made up 0.09% of Natural Investments's portfolio in Q2 2026, its #183 holding.
  • Natural Investments first reported a position in GSK in Q2 2025 and has held it in 5 quarters since.
  • Natural Investments's GSK position peaked at $414K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Natural Investments's 13F filing for Q2 2026, filed 31 Jul 2026.